127 related articles for article (PubMed ID: 38382811)
1. Engineered exosomes with enhanced stability and delivery efficiency for glioblastoma therapy.
Wang Y; Huo Y; Zhao C; Liu H; Shao Y; Zhu C; An L; Chen X; Chen Z
J Control Release; 2024 Apr; 368():170-183. PubMed ID: 38382811
[TBL] [Abstract][Full Text] [Related]
2. Exosomes and biomimetic nanovesicles-mediated anti-glioblastoma therapy: A head-to-head comparison.
Wu JY; Li YJ; Hu XB; Huang S; Luo S; Tang T; Xiang DX
J Control Release; 2021 Aug; 336():510-521. PubMed ID: 34237399
[TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy.
Chu L; Sun Y; Zhao Y; Wang A; Sun Y; Duan X; Li N; Xia H; Liu W; Sun K
Int J Pharm; 2024 May; 660():124262. PubMed ID: 38815637
[TBL] [Abstract][Full Text] [Related]
4. NIR-II Light-Driven Genetically Engineered Exosome Nanocatalysts for Efficient Phototherapy against Glioblastoma.
Fang X; Gong R; Yang D; Li C; Zhang Y; Wang Y; Nie G; Li M; Peng X; Zhang B
J Am Chem Soc; 2024 Jun; 146(22):15251-15263. PubMed ID: 38780071
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory tumor microenvironment responsive neutrophil exosomes-based drug delivery system for targeted glioma therapy.
Wang J; Tang W; Yang M; Yin Y; Li H; Hu F; Tang L; Ma X; Zhang Y; Wang Y
Biomaterials; 2021 Jun; 273():120784. PubMed ID: 33848731
[TBL] [Abstract][Full Text] [Related]
6. Embryonic Stem Cells-Derived Exosomes Endowed with Targeting Properties as Chemotherapeutics Delivery Vehicles for Glioblastoma Therapy.
Zhu Q; Ling X; Yang Y; Zhang J; Li Q; Niu X; Hu G; Chen B; Li H; Wang Y; Deng Z
Adv Sci (Weinh); 2019 Mar; 6(6):1801899. PubMed ID: 30937268
[TBL] [Abstract][Full Text] [Related]
7. Improving glioblastoma therapeutic outcomes via doxorubicin-loaded nanomicelles modified with borneol.
Meng L; Chu X; Xing H; Liu X; Xin X; Chen L; Jin M; Guan Y; Huang W; Gao Z
Int J Pharm; 2019 Aug; 567():118485. PubMed ID: 31260781
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded nanoparticle coated with endothelial cells-derived exosomes for immunogenic chemotherapy of glioblastoma.
Zhang C; Song J; Lou L; Qi X; Zhao L; Fan B; Sun G; Lv Z; Fan Z; Jiao B; Yang J
Bioeng Transl Med; 2021 Sep; 6(3):e10203. PubMed ID: 34589592
[TBL] [Abstract][Full Text] [Related]
9. Exosomes: Their role in the diagnosis, progression, metastasis, and treatment of glioblastoma.
Mousavikia SN; Darvish L; Bahreyni Toossi MT; Azimian H
Life Sci; 2024 Aug; 350():122743. PubMed ID: 38806071
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Glioma Cells' Proliferation by Doxorubicin-Loaded Exosomes via Microfluidics.
Thakur A; Sidu RK; Zou H; Alam MK; Yang M; Lee Y
Int J Nanomedicine; 2020; 15():8331-8343. PubMed ID: 33149579
[TBL] [Abstract][Full Text] [Related]
11. Blood exosomes-based targeted delivery of cPLA2 siRNA and metformin to modulate glioblastoma energy metabolism for tailoring personalized therapy.
Zhan Q; Yi K; Cui X; Li X; Yang S; Wang Q; Fang C; Tan Y; Li L; Xu C; Yuan X; Kang C
Neuro Oncol; 2022 Nov; 24(11):1871-1883. PubMed ID: 35312010
[TBL] [Abstract][Full Text] [Related]
12. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles.
Norouzi M; Yathindranath V; Thliveris JA; Kopec BM; Siahaan TJ; Miller DW
Sci Rep; 2020 Jul; 10(1):11292. PubMed ID: 32647151
[TBL] [Abstract][Full Text] [Related]
13. 'Dendrimer-Cationized-Albumin' encrusted polymeric nanoparticle improves BBB penetration and anticancer activity of doxorubicin.
Muniswamy VJ; Raval N; Gondaliya P; Tambe V; Kalia K; Tekade RK
Int J Pharm; 2019 Jan; 555():77-99. PubMed ID: 30448308
[TBL] [Abstract][Full Text] [Related]
14. Design of Y-shaped targeting material for liposome-based multifunctional glioblastoma-targeted drug delivery.
Belhadj Z; Ying M; Cao X; Hu X; Zhan C; Wei X; Gao J; Wang X; Yan Z; Lu W
J Control Release; 2017 Jun; 255():132-141. PubMed ID: 28390902
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound Facilitates Naturally Equipped Exosomes Derived from Macrophages and Blood Serum for Orthotopic Glioma Treatment.
Bai L; Liu Y; Guo K; Zhang K; Liu Q; Wang P; Wang X
ACS Appl Mater Interfaces; 2019 Apr; 11(16):14576-14587. PubMed ID: 30900870
[TBL] [Abstract][Full Text] [Related]
16. Multifunctional exosome-mimetics for targeted anti-glioblastoma therapy by manipulating protein corona.
Wu JY; Li YJ; Wang J; Hu XB; Huang S; Luo S; Xiang DX
J Nanobiotechnology; 2021 Dec; 19(1):405. PubMed ID: 34872569
[TBL] [Abstract][Full Text] [Related]
17. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
[TBL] [Abstract][Full Text] [Related]
18. Synchronous Disintegration of Ferroptosis Defense Axis via Engineered Exosome-Conjugated Magnetic Nanoparticles for Glioblastoma Therapy.
Li B; Chen X; Qiu W; Zhao R; Duan J; Zhang S; Pan Z; Zhao S; Guo Q; Qi Y; Wang W; Deng L; Ni S; Sang Y; Xue H; Liu H; Li G
Adv Sci (Weinh); 2022 Jun; 9(17):e2105451. PubMed ID: 35508804
[TBL] [Abstract][Full Text] [Related]
19. Delivery of siRNA based on engineered exosomes for glioblastoma therapy by targeting STAT3.
Liang SF; Zuo FF; Yin BC; Ye BC
Biomater Sci; 2022 Mar; 10(6):1582-1590. PubMed ID: 35179533
[TBL] [Abstract][Full Text] [Related]
20. Optimizing the Design of Blood-Brain Barrier-Penetrating Polymer-Lipid-Hybrid Nanoparticles for Delivering Anticancer Drugs to Glioblastoma.
Ahmed T; Liu FF; He C; Abbasi AZ; Cai P; Rauth AM; Henderson JT; Wu XY
Pharm Res; 2021 Nov; 38(11):1897-1914. PubMed ID: 34655006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
